{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:07:35Z","timestamp":1788480455046,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040314"],"award-info":[{"award-number":["UG1DA040314"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040316"],"award-info":[{"award-number":["UG1DA040316"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10 DA013714"],"award-info":[{"award-number":["U10 DA013714"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5UG1DA013035"],"award-info":[{"award-number":["5UG1DA013035"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1-DA015831"],"award-info":[{"award-number":["UG1-DA015831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA020024"],"award-info":[{"award-number":["UG1DA020024"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10-DA13720"],"award-info":[{"award-number":["U10-DA13720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11606-020-06389-7","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:29:53Z","timestamp":1613046593000},"page":"930-937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV"],"prefix":"10.1007","volume":"36","author":[{"given":"Judith I.","family":"Tsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Akosile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen T.","family":"Lapham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Bobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi Jo H.","family":"Yarborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Rossom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph O.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Samet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin B.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Loree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Stotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M","family":"Braciszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulin C.","family":"Hechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana E.","family":"Horigian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-4425","authenticated-orcid":false,"given":"Katharine A.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"6389_CR1","unstructured":"Centers for Disease Control and Prevention. Drug Overdose Deaths. 2018. Available at: https:\/\/www.cdc.gov\/drugoverdose\/data\/statedeaths.html. Accessed 5\/14\/2018 2019."},{"key":"6389_CR2","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health., Rockville, MD. 2018. Available at: https:\/\/www.samhsa.gov\/data\/report\/2017-nsduh-annual-national-report."},{"issue":"2","key":"6389_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med 2016;374(2):154-63. https:\/\/doi.org\/10.1056\/NEJMra1508490","journal-title":"N Engl J Med"},{"issue":"4","key":"6389_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.15288\/jsad.2013.74.605","volume":"74","author":"JS Potter","year":"2013","unstructured":"Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, et al. Buprenorphine\/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START). J Stud Alcohol Drugs 2013;74(4):605-13","journal-title":"J Stud Alcohol Drugs"},{"issue":"2","key":"6389_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/ajph.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health 2018;108(2):175-81. https:\/\/doi.org\/10.2105\/ajph.2017.304132","journal-title":"Am J Public Health"},{"issue":"3","key":"6389_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015. N Engl J Med 2016;375(3):229-39. https:\/\/doi.org\/10.1056\/NEJMoa1515195","journal-title":"N Engl J Med"},{"issue":"10","key":"6389_CR7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/cid\/ciw111","volume":"62","author":"KN Ly","year":"2016","unstructured":"Ly KN, Hughes EM, Jiles RB, Holmberg SD. Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. Clin Infect Dis 2016;62(10):1287-8. https:\/\/doi.org\/10.1093\/cid\/ciw111","journal-title":"Clin Infect Dis"},{"key":"6389_CR8","unstructured":"National Center for HIV\/AIDS VH, STD, and TB Prevention. HIV in the United States: At a Glance. Centers for Disease Control. 2018. Available at: https:\/\/www.cdc.gov\/hiv\/pdf\/statistics\/overview\/cdc-hiv-us-ataglance.pdf. Accessed Jun 2018."},{"issue":"8","key":"6389_CR9","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/add.14188","volume":"113","author":"M Hickman","year":"2018","unstructured":"Hickman M, Steer C, Tilling K, Lim AG, Marsden J, Millar T, et al. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction. 2018;113(8):1461-76. https:\/\/doi.org\/10.1111\/add.14188","journal-title":"Addiction."},{"key":"6389_CR10","doi-asserted-by":"publisher","unstructured":"Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry 2018. https:\/\/doi.org\/10.1038\/s41380-018-0094-5","DOI":"10.1038\/s41380-018-0094-5"},{"key":"6389_CR11","unstructured":"National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Medication-Assisted Treatment for Opioid Use Disorder. In: Mancher M, Leshner AI, editors. Medications for Opioid Use Disorder Save Lives. Washington (DC) 2019."},{"issue":"Suppl 1","key":"6389_CR12","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"FL Altice","year":"2011","unstructured":"Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr 2011;56 Suppl 1:S22-32. https:\/\/doi.org\/10.1097\/QAI.0b013e318209751e","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"6389_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/QAI.0000000000001634","volume":"78","author":"SA Springer","year":"2018","unstructured":"Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, et al. Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial. J Acquir Immune Defic Syndr 2018;78(1):43-53. https:\/\/doi.org\/10.1097\/QAI.0000000000001634","journal-title":"J Acquir Immune Defic Syndr"},{"key":"6389_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2017.01.015","volume":"75","author":"BL Norton","year":"2017","unstructured":"Norton BL, Beitin A, Glenn M, DeLuca J, Litwin AH, Cunningham CO. Retention in buprenorphine treatment is associated with improved HCV care outcomes. J Subst Abus Treat 2017;75:38-42. https:\/\/doi.org\/10.1016\/j.jsat.2017.01.015","journal-title":"J Subst Abus Treat"},{"issue":"12","key":"6389_CR15","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1111\/add.12682","volume":"109","author":"S Nolan","year":"2014","unstructured":"Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, et al. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction. 2014;109(12):2053-9. https:\/\/doi.org\/10.1111\/add.12682","journal-title":"Addiction."},{"issue":"6","key":"6389_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5694\/mja13.00153","volume":"201","author":"B White","year":"2014","unstructured":"White B, Dore GJ, Lloyd AR, Rawlinson WD, Maher L. Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study. Med J Aust 2014;201(6):326-9","journal-title":"Med J Aust"},{"issue":"12","key":"6389_CR17","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","volume":"174","author":"JI Tsui","year":"2014","unstructured":"Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med 2014;174(12):1974-81. https:\/\/doi.org\/10.1001\/jamainternmed.2014.5416","journal-title":"JAMA Intern Med"},{"key":"6389_CR18","doi-asserted-by":"publisher","first-page":"Cd004145","DOI":"10.1002\/14651858.CD004145.pub4","volume":"8","author":"L Gowing","year":"2011","unstructured":"Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011(8):Cd004145. https:\/\/doi.org\/10.1002\/14651858.CD004145.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"6389_CR19","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1136\/bmj.e5945","volume":"345","author":"GJ MacArthur","year":"2012","unstructured":"MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ. 2012;345:e5945. https:\/\/doi.org\/10.1136\/bmj.e5945","journal-title":"BMJ."},{"key":"6389_CR20","unstructured":"Interagency Pain Research Coordinating Committee. National Pain Strategy: A Comprehenisve Population Health-Level Strategy for Pain. In: Department of Health and Human Services, editor. Washington, DC 2015"},{"issue":"e2","key":"6389_CR21","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1136\/amiajnl-2013-001856","volume":"20","author":"TY Tian","year":"2013","unstructured":"Tian TY, Zlateva I, Anderson DR. Using electronic health records data to identify patients with chronic pain in a primary care setting. J Am Med Inform Assoc 2013;20(e2):e275-80. https:\/\/doi.org\/10.1136\/amiajnl-2013-001856","journal-title":"J Am Med Inform Assoc"},{"key":"6389_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.drugalcdep.2018.03.047","volume":"188","author":"MD Owens","year":"2018","unstructured":"Owens MD, Ioannou GN, Tsui JL, Edelman EJ, Greene PA, Williams EC. Receipt of alcohol-related care among patients with HCV and unhealthy alcohol use. Drug Alcohol Depend 2018;188:79-85. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.03.047","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"6389_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s10461-016-1584-6","volume":"21","author":"B Hartzler","year":"2017","unstructured":"Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav 2017;21(4):1138-48. https:\/\/doi.org\/10.1007\/s10461-016-1584-6","journal-title":"AIDS Behav"},{"key":"6389_CR24","unstructured":"National Center for HIV\/AIDS VH, STD, and TB Prevention. New Hepatitis C Infections Nearly Tripled over Five Years. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/2017\/Hepatitis-Surveillance-Press-Release.html2017"},{"key":"6389_CR25","unstructured":"National Center for HIV\/AIDS VH, STD, and TB Prevention. Injection Drug Use and HIV Risk. 2018. Available at: https:\/\/www.cdc.gov\/hiv\/risk\/idu.html. Accessed Jun 10, 2020"},{"issue":"16","key":"6389_CR26","first-page":"443","volume":"64","author":"C Conrad","year":"2015","unstructured":"Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone--Indiana, 2015. MMWR Morb Mortal Wkly Rep 2015;64(16):443-4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"6389_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","volume":"68","author":"K Cranston","year":"2019","unstructured":"Cranston K, Alpren C, John B, Dawson E, Roosevelt K, Burrage A, et al. Notes from the Field: HIV Diagnoses Among Persons Who Inject Drugs - Northeastern Massachusetts, 2015-2018. MMWR Morb Mortal Wkly Rep. 2019;68(10):253-4. https:\/\/doi.org\/10.15585\/mmwr.mm6810a6","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"15","key":"6389_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","volume":"68","author":"MR Golden","year":"2019","unstructured":"Golden MR, Lechtenberg R, Glick SN, Dombrowski J, Duchin J, Reuer JR, et al. Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs - Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344-9. https:\/\/doi.org\/10.15585\/mmwr.mm6815a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"6389_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpainsymman.2007.08.013","volume":"36","author":"AJ Whitehead","year":"2008","unstructured":"Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. J Pain Symptom Manag 2008;36(1):39-45. https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.08.013","journal-title":"J Pain Symptom Manag"},{"issue":"7","key":"6389_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1080\/09540121.2011.642989","volume":"24","author":"JI Tsui","year":"2012","unstructured":"Tsui JI, Cheng DM, Libman H, Bridden C, Samet J. Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults. AIDS Care 2012;24(7):820-7. https:\/\/doi.org\/10.1080\/09540121.2011.642989","journal-title":"AIDS Care"},{"issue":"2","key":"6389_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10550887.2011.554775","volume":"30","author":"JI Tsui","year":"2011","unstructured":"Tsui JI, Herman DS, Kettavong M, Anderson BJ, Stein MD. Chronic pain and hepatitis C virus infection in opioid dependent injection drug users. J Addict Dis 2011;30(2):91-7. https:\/\/doi.org\/10.1080\/10550887.2011.554775","journal-title":"J Addict Dis"},{"issue":"1","key":"6389_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11606-012-2189-z","volume":"28","author":"EJ Edelman","year":"2013","unstructured":"Edelman EJ, Gordon K, Becker WC, Goulet JL, Skanderson M, Gaither JR, et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med 2013;28(1):82-90. https:\/\/doi.org\/10.1007\/s11606-012-2189-z","journal-title":"J Gen Intern Med"},{"issue":"3","key":"6389_CR33","first-page":"120","volume":"23","author":"JS Merlin","year":"2015","unstructured":"Merlin JS. Chronic Pain in Patients With HIV Infection: What Clinicians Need To Know. Top Antiviral Med 2015;23(3):120-4","journal-title":"Top Antiviral Med"},{"issue":"1","key":"6389_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/QAI.0000000000001741","volume":"79","author":"JS Merlin","year":"2018","unstructured":"Merlin JS, Long D, Becker WC, Cachay ER, Christopoulos KA, Claborn K, et al. Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 2018;79(1):77-82. https:\/\/doi.org\/10.1097\/QAI.0000000000001741","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"6389_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pain.2007.02.014","volume":"129","author":"MJ Edlund","year":"2007","unstructured":"Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355-62. https:\/\/doi.org\/10.1016\/j.pain.2007.02.014","journal-title":"Pain."},{"key":"6389_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend 2016;169:117-27. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.10.015","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"6389_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ADM.0000000000000408","volume":"12","author":"CP Thomas","year":"2018","unstructured":"Thomas CP, Ritter GA, Harris AHS, Garnick DW, Freedman KI, Herbert B. Applying American Society of Addiction Medicine performance measures in commercial health insurance and services data. J Addict Med 2018;12(4):287-94. https:\/\/doi.org\/10.1097\/ADM.0000000000000408","journal-title":"J Addict Med"},{"issue":"2","key":"6389_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","volume":"39","author":"JJ Wyse","year":"2018","unstructured":"Wyse JJ, Gordon AJ, Dobscha SK, Morasco BJ, Tiffany E, Drexler K, et al. Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Subst Abus 2018;39(2):139-44. https:\/\/doi.org\/10.1080\/08897077.2018.1452327","journal-title":"Subst Abus"},{"key":"6389_CR39","doi-asserted-by":"publisher","unstructured":"Tsui JI, Burt R, Thiede H, Glick SN. Utilization of buprenorphine and methadone among opioid users who inject drugs. Subst Abus 2017:1-6. https:\/\/doi.org\/10.1080\/08897077.2017.1363844","DOI":"10.1080\/08897077.2017.1363844"},{"key":"6389_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","volume":"85","author":"JR Morgan","year":"2018","unstructured":"Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J Subst Abus Treat 2018;85:90-6. https:\/\/doi.org\/10.1016\/j.jsat.2017.07.001","journal-title":"J Subst Abus Treat"},{"key":"6389_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","volume":"198","author":"JJ Wyse","year":"2019","unstructured":"Wyse JJ, Robbins JL, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, et al. Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug Alcohol Depend 2019;198:70-5. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.038","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"6389_CR42","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/QAI.0b013e31820a9a97","volume":"56","author":"R Finkelstein","year":"2011","unstructured":"Finkelstein R, Netherland J, Sylla L, Gourevitch MN, Cajina A, Cheever L, et al. Policy implications of integrating buprenorphine\/naloxone treatment and HIV care. J Acquir Immune Defic Syndr 2011;56 Suppl 1:S98-S104. https:\/\/doi.org\/10.1097\/QAI.0b013e31820a9a97","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"6389_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jsat.2007.11.005","volume":"35","author":"PT Korthuis","year":"2008","unstructured":"Korthuis PT, Josephs JS, Fleishman JA, Hellinger J, Himelhoch S, Chander G, et al. Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions. J Subst Abus Treat 2008;35(3):294-303. https:\/\/doi.org\/10.1016\/j.jsat.2007.11.005","journal-title":"J Subst Abus Treat"},{"key":"6389_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","volume":"160","author":"A Manhapra","year":"2016","unstructured":"Manhapra A, Quinones L, Rosenheck R. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug Alcohol Depend 2016;160:82-9. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.035","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"6389_CR45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08897077.2013.819828","volume":"35","author":"MI Fingerhood","year":"2014","unstructured":"Fingerhood MI, King VL, Brooner RK, Rastegar DA. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment. Subst Abus 2014;35(2):122-6. https:\/\/doi.org\/10.1080\/08897077.2013.819828","journal-title":"Subst Abus"},{"issue":"8","key":"6389_CR46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","volume":"30","author":"EJ Edelman","year":"2013","unstructured":"Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013;30(8):613-28. https:\/\/doi.org\/10.1007\/s40266-013-0093-9","journal-title":"Drugs Aging"},{"key":"6389_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jsat.2016.06.002","volume":"68","author":"JM Tetrault","year":"2016","unstructured":"Tetrault JM, Tate JP, Edelman EJ, Gordon AJ, Lo Re V, 3rd, Lim JK, et al. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. J Subst Abus Treat 2016;68:62-7. https:\/\/doi.org\/10.1016\/j.jsat.2016.06.002","journal-title":"J Subst Abus Treat"},{"issue":"6","key":"6389_CR48","doi-asserted-by":"publisher","first-page":"991","DOI":"10.15288\/jsad.2012.73.991","volume":"73","author":"MC Mitchell","year":"2012","unstructured":"Mitchell MC, Memisoglu A, Silverman BL. Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection. J Stud Alcohol Drugs 2012;73(6):991-7","journal-title":"J Stud Alcohol Drugs"},{"issue":"3","key":"6389_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","volume":"15","author":"KM Rich","year":"2018","unstructured":"Rich KM, Bia J, Altice FL, Feinberg J. Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV? Curr HIV\/AIDS Rep 2018;15(3):266-75. https:\/\/doi.org\/10.1007\/s11904-018-0396-x","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"6389_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/08964289.2013.866540","volume":"40","author":"R Durvasula","year":"2014","unstructured":"Durvasula R, Miller TR. Substance abuse treatment in persons with HIV\/AIDS: challenges in managing triple diagnosis. Behav Med 2014;40(2):43-52. https:\/\/doi.org\/10.1080\/08964289.2013.866540","journal-title":"Behav Med"},{"key":"6389_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jsat.2015.07.007","volume":"59","author":"AY Walley","year":"2015","unstructured":"Walley AY, Palmisano J, Sorensen-Alawad A, Chaisson C, Raj A, Samet JH, et al. Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection. J Subst Abus Treat 2015;59:59-66. https:\/\/doi.org\/10.1016\/j.jsat.2015.07.007","journal-title":"J Subst Abus Treat"},{"issue":"9","key":"6389_CR52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s11606-009-1043-4","volume":"24","author":"AY Walley","year":"2009","unstructured":"Walley AY, Farrar D, Cheng DM, Alford DP, Samet JH. Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? A patient safety issue. J Gen Intern Med 2009;24(9):1007-11. https:\/\/doi.org\/10.1007\/s11606-009-1043-4","journal-title":"J Gen Intern Med"},{"key":"6389_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1472-6963-12-18","volume":"12","author":"HM Kim","year":"2012","unstructured":"Kim HM, Smith EG, Stano CM, Ganoczy D, Zivin K, Walters H, et al. Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res 2012;12:18. https:\/\/doi.org\/10.1186\/1472-6963-12-18","journal-title":"BMC Health Serv Res"},{"issue":"10","key":"6389_CR54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/00005650-200410000-00004","volume":"42","author":"LS Steele","year":"2004","unstructured":"Steele LS, Glazier RH, Lin E, Evans M. Using administrative data to measure ambulatory mental health service provision in primary care. Med Care 2004;42(10):960-5","journal-title":"Med Care"},{"issue":"8","key":"6389_CR55","first-page":"721","volume":"49","author":"M Valenstein","year":"2000","unstructured":"Valenstein M, Ritsema T, Green L, Blow FC, Mitchinson A, McCarthy JF, et al. Targeting quality improvement activities for depression. Implications of using administrative data. J Fam Pract 2000;49(8):721-8","journal-title":"J Fam Pract"},{"issue":"6","key":"6389_CR56","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/hep.25556","volume":"55","author":"MM Denniston","year":"2012","unstructured":"Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012;55(6):1652-61. https:\/\/doi.org\/10.1002\/hep.25556","journal-title":"Hepatology."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06389-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06389-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T01:22:30Z","timestamp":1644456150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06389-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6389"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06389-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"Dr. Bobbi Jo H. Yarborough has received support through her institution from Syneos Health to conduct FDA-mandated post-marketing research on the risks of opioid analgesic use. Dr. Cynthia Campbell has received research support through her institution from the Industry PMR Consortium, a consortium of companies working together to conduct post-marketing studies required by the Food and Drug Administration that assess known risks related to opioid analgesic use.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}